Christopher Gibson sold $287K of Recursion Pharmaceuticals (RXRX)

Executed Jan 8 2025, disclosed Jan 13 2025, 5 days later, against a two-business-day limit.

Value, as filed

$287K

40,000 sh across 2 lots

Executed

Jan 8 2025

the trade date, as filed

Disclosed

Jan 13 2025

5 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christopher Gibson Director profile →

Christopher Gibson (Director) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales), most often in Recursion Pharmaceuticals, Inc. (RXRX). The largest single filing was $604K of RXRX (100,000 sh × $6.04, as filed), executed Oct 10 2025.

The name

RXRX

Recursion Pharmaceuticals, Inc. RXRX · Healthcare · 38 filings in 24 months ticker →

Healthcare · Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating techn…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Gibson in RXRX

RXRXSALE Recursion Pharmaceuticals, Inc. $145K
40,000 sh × $3.62
Exec Jun 5
Filed Jun 5 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $123K
40,000 sh × $3.08
Exec May 22
Filed May 27 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $135K
40,000 sh × $3.37
Exec May 7
Filed May 8 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $144K
40,000 sh × $3.61
Exec Apr 22
Filed Apr 24 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $124K
40,000 sh × $3.10
Exec Apr 7
Filed Apr 8 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $130K
40,000 sh × $3.25
Exec Mar 23
Filed Mar 25 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $138K
40,000 sh × $3.46
Exec Feb 19
Filed Feb 19 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $165K
40,000 sh × $4.12
Exec Feb 4
Filed Feb 6 · 5:30 PM ET